-
FDA Approval of Fruquintinib Expands Later-Line Treatment Options in mCRC
John L. Marshall, MD, sheds light on the significance of the FDA approval of fruquintinib for patients with heavily pretreated metastatic colorectal cancer and discusses the efficacy and safety data from the FRESCO and FRESCO-2 trials that supported the decision in this population.
Category: News
-
Luminary Awards Highlight Exemplary Work of Experts in GI Cancers
The Luminary Awards in GI Cancers are designed to highlight the lifetime achievements of individuals who have dedicated their careers to expanding the knowledge of the GI cancer community.
Category: News
-
Mixed CRC Screening Messaging. Confusing? Some Docs Think So
Dr. Marshall discusses updated colorectal cancer screening guidance from the American College of Physicians
Category: News
-
Dr. Marshall discusses updates for the management of patients with metastatic colorectal cancer
Dr. Marshall joins experts for an overview on metastatic colorectal cancer, the latest advancements in treatments for metastatic colorectal cancer, and the future considerations for metastatic colorectal cancer.
Category: News
-
Ivana Peran, PhD Ruesch Collaborator Granted PanCAn Career Development Funding
“Role of Stromal Cadherin 11 in Chemotherapy Response in Pancreatic Cancer”. This grant is awarded to researchers new in the field who we hope will go on to make groundbreaking discoveries.
Category: News
-
Maximizing Patient Quality of Life through Shared Decision Making in Metastatic Colorectal Cancer
Maximizing Patient Quality of Life through Shared Decision Making in Metastatic Colorectal Cancer
Category: News
-
Perioperative therapy landscape for locally advanced, resectable esophageal cancer: an updated literature review
Dr. Mukherji and team present an updated review of the main historical and recently emerging studies that impact the perioperative management of patients with locally advanced, upfront-resectable EC.
Category: News
-
Novel Combination Strategies in BRAF-Mutant Metastatic Colorectal Cancer
John Marshall, MD joins experts in discussing novel combination and immunotherapy strategies within BRAF-mutated metastatic colorectal cancer management.
Category: News
-
Implementing precision medicine approaches in colon cancer
Dr. John L. Marshall discusses the role of precision medicine in the treatment of colon cancer
Category: News
-
Advances in Precision Medicine Propel Personalized GI Cancer Care
Eileen O’Reilly, MD, and Benjamin Weinberg, MD, discuss the importance of conducting biomarker testing as the gastrointestinal cancer treatment arena continues to evolve, the need for increased gene fusion testing, and the negative effects of inadequate biomarker testing in the gastrointestinal cancer population.
Category: News